What a great chat with Dr. Andrea Jungaberle, the co-founder of Berlin’s MIND Foundation, one of the largest European psychedelic-assisted therapy thinktanks. With her very thoughtful and cautionary approach, Andrea talks about the ethics of disruptive therapies such as MDMA Therapy, the dangers implicit in forming strong and speedy connections, the special responsibilities of training organizations and therapists in MDMA therapy, the need for constraint and de-acceleration in the field, and issues related to training, regulation, access, and of course the future of life on earth. Andrea also talks about MIND’s programming, including their Drug Science Program, reportedly the most comprehensive psychedelic drug science program in the known universe, and of course the spectacular INSIGHT 2021 conference which is just about to begin (September 5-9) and is not to be missed – discounted online tickets @ https://insight-conference.eu/tickets/